**Core Concept**
Rivastigmine and Donepezil are cholinesterase inhibitors used in the management of Alzheimer's disease, a neurodegenerative disorder characterized by progressive cognitive decline. These medications work by inhibiting the enzyme acetylcholinesterase, which breaks down acetylcholine, a neurotransmitter involved in memory and learning.

**Why the Correct Answer is Right**
The mechanism of action of Rivastigmine and Donepezil involves the inhibition of acetylcholinesterase, thereby increasing the concentration of acetylcholine in the brain. This leads to improved cholinergic transmission, which in turn enhances cognitive function in patients with Alzheimer's disease. The use of these medications has been shown to slow the progression of cognitive decline and improve quality of life for patients with Alzheimer's disease.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because Rivastigmine and Donepezil are not primarily used in the management of Parkinson's disease, although they may be used off-label for this condition. Parkinson's disease is typically managed with dopaminergic agents such as levodopa and dopamine agonists.
* **Option B:** This option is incorrect because Rivastigmine and Donepezil are not primarily used in the management of Huntington's disease, a neurodegenerative disorder characterized by chorea and cognitive decline. Huntington's disease is typically managed with medications that reduce chorea and alleviate symptoms.
* **Option D:** This option is incorrect because Rivastigmine and Donepezil are not primarily used in the management of multiple sclerosis, a chronic autoimmune disease that affects the central nervous system. Multiple sclerosis is typically managed with disease-modifying therapies and medications that alleviate symptoms.

**Clinical Pearl / High-Yield Fact**
Rivastigmine and Donepezil are examples of disease-modifying therapies for Alzheimer's disease, and their use has been shown to slow the progression of cognitive decline and improve quality of life for patients with this condition. These medications are most effective when used early in the course of the disease.

**Correct Answer: C. Alzheimer's disease**